• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年至2009年期间,来自西班牙全国硬皮病登记处(RESCLE)的987例系统性硬化症患者的死亡模式变化。

Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE).

作者信息

Rubio-Rivas Manuel, Simeón-Aznar Carmen Pilar, Velasco César, Marí-Alfonso Begoña, Espinosa Gerard, Corbella Xavier, Colunga-Argüelles Dolores, Egurbide-Arberas Maria Victoria, Ortego-Centeno Norberto, Vargas-Hitos José Antonio, Freire Mayka, Ríos-Blanco Juan José, Trapiella-Martínez Luis, Rodríguez-Carballeira Mónica, Fonollosa-Pla Vicent

机构信息

Autoimmune Diseases Unit, Department of Internal Medicine, Bellvitge University Hospital-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

Vall d'Hebron University Hospital, Department of Internal Medicine, Barcelona, Spain.

出版信息

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):40-47. Epub 2017 Feb 6.

PMID:28229826
Abstract

OBJECTIVES

To determine the changes in the pattern of death of patients with systemic sclerosis (SSc) throughout 20 years.

METHODS

Data were collected from the Spanish Scleroderma Registry (RESCLE), retrospective multicentre database from 1990 to 2009. SSc-related and SSc-non related causes of death were assessed.

RESULTS

987 patients were recruited. Overall standardised mortality ratio (SMR) was 2.34 (2.24-2.44). SSc-related causes of death were responsible of 72% of all deaths of those patients diagnosed within 1990-99 vs. 48% within 2000-09 (p=0.006). Relative pulmonary death rate was stable over time (68.1% within 1990-99 vs. 63.9% within 2000-09, p=0.815). Relative renal death rate was decreasing over time (17% within 1990-99 vs. 5.5% within 2000-09, p=0.175). Heart distribution tripled its ratio (12.8% within 1990-99 vs. 30.6% within 2000-09, p=0.058).

CONCLUSIONS

SSc-related causes of death were decreasing over time and, among them, pulmonary involvement was the leading cause of death in both decades. The ratio of renal causes decreased since 1990 at the time that the ratio of cardiac causes increased.

摘要

目的

确定20年间系统性硬化症(SSc)患者的死亡模式变化。

方法

数据收集自西班牙硬皮病注册中心(RESCLE),这是一个1990年至2009年的回顾性多中心数据库。评估了与SSc相关和与SSc无关的死亡原因。

结果

招募了987名患者。总体标准化死亡率(SMR)为2.34(2.24 - 2.44)。1990 - 1999年诊断的患者中,与SSc相关的死亡原因占所有死亡的72%,而2000 - 2009年为48%(p = 0.006)。相对肺部死亡率随时间保持稳定(1990 - 1999年为68.1%,2000 - 2009年为63.9%,p = 0.815)。相对肾脏死亡率随时间下降(1990 - 1999年为17%,2000 - 2009年为5.5%,p = 0.175)。心脏相关死亡比例增加了两倍(1990 - 1999年为12.8%,2000 - 2009年为30.6%,p = 0.058)。

结论

与SSc相关的死亡原因随时间减少,其中肺部受累是这两个十年中的主要死亡原因。自1990年以来,肾脏相关原因的比例下降,而心脏相关原因的比例增加。

相似文献

1
Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE).1990年至2009年期间,来自西班牙全国硬皮病登记处(RESCLE)的987例系统性硬化症患者的死亡模式变化。
Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):40-47. Epub 2017 Feb 6.
2
Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.系统性硬化症的指端溃疡和皮肤亚组:西班牙RESCLE注册研究中的临床、免疫学、甲襞毛细血管镜检查及生存差异
Semin Arthritis Rheum. 2016 Oct;46(2):200-208. doi: 10.1016/j.semarthrit.2016.04.007. Epub 2016 May 18.
3
Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry.肝膽系統受累在全身性硬皮病和皮膚亞型中的特徵和生存:來自西班牙 RESCLE 登記的患者。
Semin Arthritis Rheum. 2018 Jun;47(6):849-857. doi: 10.1016/j.semarthrit.2017.10.004. Epub 2017 Oct 6.
4
Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation.基于 RESCLE 队列,西班牙硬皮病风险评分(RESCLESCORE)可在硬皮病患者诊断时预测 15 年全因死亡率:推导和内部验证。
Autoimmun Rev. 2020 May;19(5):102507. doi: 10.1016/j.autrev.2020.102507. Epub 2020 Mar 17.
5
Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran.系统性硬化症患者的生存情况及死亡原因:来自伊朗的一项单中心登记报告。
Rheumatol Int. 2016 Jul;36(7):925-34. doi: 10.1007/s00296-016-3475-6. Epub 2016 Apr 9.
6
Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.西班牙系统性硬皮病网络注册研究:根据皮肤亚型和免疫状态的临床表现。
Semin Arthritis Rheum. 2012 Jun;41(6):789-800. doi: 10.1016/j.semarthrit.2011.10.004. Epub 2011 Dec 12.
7
Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death.西班牙系统性硬化症网络登记处:生存率、预后因素及死亡原因
Medicine (Baltimore). 2015 Oct;94(43):e1728. doi: 10.1097/MD.0000000000001728.
8
Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.在西班牙系统性硬化症患者中与死亡率相关的生存、死因和危险因素:来自一家大学医院的结果。
Semin Arthritis Rheum. 2010 Feb;39(4):285-93. doi: 10.1016/j.semarthrit.2009.06.002. Epub 2009 Sep 25.
9
Mortality in the Waikato Hospital Systemic Sclerosis Cohort.怀卡托医院系统性硬化症队列中的死亡率。
Int J Rheum Dis. 2018 Jan;21(1):253-260. doi: 10.1111/1756-185X.13111. Epub 2017 Jun 4.
10
Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.在西班牙硬皮病登记处(RESCLE)队列中非常早期和早期系统性硬化症。
Autoimmun Rev. 2017 Aug;16(8):796-802. doi: 10.1016/j.autrev.2017.05.013. Epub 2017 May 28.

引用本文的文献

1
Assessment of Neutrophil-Lymphocyte Ratio and Systemic Immune-Inflammation Index in Systemic Scleroderma Patients with Focus on Cardiopulmonary Manifestations.系统性硬化症患者中性粒细胞与淋巴细胞比值及全身免疫炎症指数的评估:聚焦心肺表现
Curr Health Sci J. 2024 Jul-Sep;50(3):421-427. doi: 10.12865/CHSJ.50.03.09. Epub 2024 Sep 30.
2
Comprehensive description of the prevalence, serological and clinical characteristics, and visceral involvement of systemic sclerosis (scleroderma) in a large cohort from the United Arab Emirates Systemic Sclerosis Registry.来自阿拉伯联合酋长国系统性硬化症注册中心的一个大型队列中系统性硬化症(硬皮病)的患病率、血清学和临床特征以及内脏受累情况的综合描述。
J Scleroderma Relat Disord. 2023 Jun;8(2):137-150. doi: 10.1177/23971983221145788. Epub 2023 Jan 5.
3
Update on assessment and management of primary cardiac involvement in systemic sclerosis.系统性硬化症中心脏原发性受累的评估与管理进展
J Scleroderma Relat Disord. 2018 Feb;3(1):53-65. doi: 10.1177/2397198317747441. Epub 2018 Apr 4.
4
Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality.局限型硬皮病、弥漫型硬皮病和系统性硬化症的生存和死亡率预测因素。
Arthritis Res Ther. 2021 Dec 7;23(1):295. doi: 10.1186/s13075-021-02672-y.
5
Trends in incidence, mortality, and causes of death associated with systemic sclerosis in Denmark between 1995 and 2015: a nationwide cohort study.1995年至2015年间丹麦系统性硬化症的发病率、死亡率及死亡原因趋势:一项全国性队列研究。
BMC Rheumatol. 2018 Dec 7;2:36. doi: 10.1186/s41927-018-0043-6. eCollection 2018.
6
Overall and sex- and disease subtype-specific mortality in patients with systemic sclerosis : An updated meta-analysis.系统性硬化症患者的总体死亡率以及按性别和疾病亚型划分的死亡率:一项更新的荟萃分析。
Z Rheumatol. 2019 Mar;78(2):195-201. doi: 10.1007/s00393-018-0492-8.
7
Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.系统性硬化症的间质性肺疾病:来自西班牙硬皮病研究组的数据。
Rheumatol Int. 2018 Mar;38(3):363-374. doi: 10.1007/s00296-017-3916-x. Epub 2018 Jan 10.
8
Assessment of hospitalization and mortality of scleroderma in-patients: a thirteen-year study.硬皮病住院患者的住院情况及死亡率评估:一项为期13年的研究。
Reumatologia. 2017;55(4):163-168. doi: 10.5114/reum.2017.69776. Epub 2017 Aug 31.